Alembic Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for prazosin hydrochloride capsules USP in 1 mg, 2 mg, and 5 mg strengths, the company said in an exchange filing.
The drug is a generic version of Pfizer Inc's Minipress capsules.
It is indicated for the treatment of hypertension to lower blood pressure.
According to data by IQVIA, the drug had sales of approximately $50 mln for the 12-month period ended December.
Mumbai News: BEST's Owned Bus Fleet Shrinks To Just 17% Amid Rising Reliance On Private Operators
Mumbai Tragedy: Mankhurd Man Dies By Suicide Amid Financial Distress, Father Alleges Money Fraud As Trigger
Punjab News: Khadoor Sahib MP Amritpal’s Uncle Harjit Singh Refuses Treatment, Sent Back To Bathinda Jail After Hospital Visit
CBI Arrests Arambai Tenggol Member In Manipur Violence Case, Tension Escalates
Shares of the company traded 0.8% lower at ₹521.05 on the NSE, at 09:15 IST.
